Characteristics of Clinical Trials Launched Early in the COVID-19 Pandemic in the US and in France.

Please login or register to bookmark this article
Bookmark this %label%

Based on hierarchical classification and logistic regression of early US and French COVID-19 clinical trials we show that despite the registration of a large number of trials, only a minority had characteristics usually associated with providing robust and relevant evidence.

View the full article @ The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics
Get PDF with LibKey

Authors: Véronique Raimond, Julien Mousquès, Jerry Avorn, Aaron S Kesselheim